Anti-Mouse CD8a (Ly 2) Purified (Clone YTS 169.4) (rat IgG2b)
Référence MBS520216-0,25mg
Conditionnement : 0.25mg
Marque : MyBiosource
CD8a (Ly 2) Antibody – Rat Monoclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS520216purified anti-CD8a (Ly 2) monoclonal antibody reacts with a protein of approximately 30 kDa found on mouse thymocytes and mouse cytotoxic/suppressor T cells. It does not bind to mouse helper/inducer T cells. It binds to T lymphocytes from all mouse strains… More details
Product Overview
Online Datasheet in PDFProduct Name
CD8a (Ly 2), Monoclonal Antibody
Full Product Name
Anti-Mouse CD8a (Ly 2) Purified (Clone YTS 169.4) (rat IgG2b)
Product Gene Name
anti-CD8a (Ly 2) antibody
Product Synonym Names
CD8a (Ly 2) Purified (Clone YTS 169.4) (rat IgG2b); Anti-Mouse CD8a (Ly 2) Monoclonal Antibody
Clonality
Monoclonal
Isotype
Rat IgG2b
Clone Number
YTS 169 AG 101 HL
Host
Rat
Species Reactivity
Mouse
Form/Format
Purified
Concentration
1.0 mg/ml (lot specific)
Specificity
CD8a (Ly 2; Lyt 2) (Mouse CD8a (Ly 2))
Specifications:
Clone: YTS 169AG 101HL
Hybridoma Production:
Immunization: Immunogen: Mouse Ly-2 thymocytes
Donor: (Lou x DA) F1 rat
Fusion Partner: Myeloma Y3/Ag1.2.3
Specificity: Mouse CD8a (Ly 2)
Strains Tested: C57BL/6, BALB/c, AKR/J, C3H/He
Positive: C57BL/6, BALB/c, AKR/J, C3H/He
Negative: None
Specifications:
Clone: YTS 169AG 101HL
Hybridoma Production:
Immunization: Immunogen: Mouse Ly-2 thymocytes
Donor: (Lou x DA) F1 rat
Fusion Partner: Myeloma Y3/Ag1.2.3
Specificity: Mouse CD8a (Ly 2)
Strains Tested: C57BL/6, BALB/c, AKR/J, C3H/He
Positive: C57BL/6, BALB/c, AKR/J, C3H/He
Negative: None
Preparation and Storage
Store Ascites at -20 degree C. For all other formats, store at 4 degree C. DO NOT FREEZE APC and PE conjugates. For long term storage (Purified, Biotin, FITC and No Azide), aliquot and freeze unused portion at -20 degree C in volumes appropriate for single usage. Avoid freeze/thaw cycles.
Molecular Weight
25,729 Da
Chromosome Location
Chromosome: 2; NC_000002.11 (87011728..87035519, complement). Location: 2p12
OMIM
186910
Immunogen
Mouse Ly-2 thymocytes
Donor
(Lou x DA) F1 rat
Fusion Partner
myeloma Y3/Ag1.2.3
Presentation
Purified IgG buffered in PBS and 0.02% NaN3. (Purified from ascitic fluid via Protein G Chromatography). For maximum recovery of contents, spin down tube before use.
Applications Tested/Suitable for anti-CD8a (Ly 2) antibody
Immunohistochemistry (IHC), Cytotoxic Assay (CA), Flow Cytometry (FC/FACS), In-Vivo Depletion (IV)
Other Notes
Small volumes of anti-CD8a (Ly 2) antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for CD8a (Ly 2) purchase
MBS520216 is an antibody targeting CD8a (Ly 2). Also known as Anti-Mouse CD8a (Ly 2) Purified (Clone YTS 169.4) (rat IgG2b). Reactive in Mouse. Host: Rat.
Additional Details
NCBI/Uniprot data below describe general gene information for CD8a (Ly 2). It may not necessarily be applicable to this product.
NCBI Official Full Name
CD8a molecule
NCBI Official Synonym Full Names
CD8a molecule
NCBI Official Symbol
CD8A
NCBI Official Synonym Symbols
CD8; MAL; p32; Leu2
UniProt Protein Name
T-cell surface glycoprotein CD8 alpha chain
UniProt Synonym Protein Names
T-lymphocyte differentiation antigen T8/Leu-2
UniProt Gene Name
CD8A
UniProt Synonym Gene Names
MAL
UniProt Entry Name
CD8A_HUMAN
NCBI Protein Information
T-cell surface glycoprotein CD8 alpha chain; T8 T-cell antigen; T cell co-receptor; OKT8 T-cell antigen; T-cell antigen Leu2; Leu2 T-lymphocyte antigen; CD8 antigen, alpha polypeptide (p32); T-lymphocyte differentiation antigen T8/Leu-2
NCBI Summary for CD8a (Ly 2)
The CD8 antigen is a cell surface glycoprotein found on most cytotoxic T lymphocytes that mediates efficient cell-cell interactions within the immune system. The CD8 antigen acts as a coreceptor with the T-cell receptor on the T lymphocyte to recognize antigens displayed by an antigen presenting cell in the context of class I MHC molecules. The coreceptor functions as either a homodimer composed of two alpha chains or as a heterodimer composed of one alpha and one beta chain. Both alpha and beta chains share significant homology to immunoglobulin variable light chains. This gene encodes the CD8 alpha chain. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]
Show more UniProt Comments for CD8a (Ly 2)
Function: Identifies cytotoxic/suppressor T-cells that interact with MHC class I bearing targets. CD8 is thought to play a role in the process of T-cell mediated killing. CD8 alpha chains binds to class I MHC molecules alpha-3 domains.
Subunit structure: In general heterodimer of an alpha and a beta chain linked by two disulfide bonds. Can also form homodimers. Shown to be expressed as heterodimer on thymocytes and as homodimer on peripheral blood T-lymphocytes. Interacts with the MHC class I HLA-A/B2M dimer. Interacts with LCK in a zinc-dependent manner. Ref.9
Subcellular location: Isoform 1: Cell membrane; Single-pass type I membrane protein. Isoform 2: Secreted.
Post-translational modification: All of the five most C-terminal cysteines form inter-chain disulfide bonds in dimers and higher multimers, while the four N-terminal cysteines do not
By similarity.
Involvement in disease: Familial CD8 deficiency (CD8 deficiency) [MIM:608957]: Novel autosomal recessive immunologic defect characterized by absence of CD8+ cells, leading to recurrent bacterial infections.Note: The disease is caused by mutations affecting the gene represented in this entry.
Sequence similarities: Contains 1 Ig-like V-type (immunoglobulin-like) domain.
Show more Subunit structure: In general heterodimer of an alpha and a beta chain linked by two disulfide bonds. Can also form homodimers. Shown to be expressed as heterodimer on thymocytes and as homodimer on peripheral blood T-lymphocytes. Interacts with the MHC class I HLA-A/B2M dimer. Interacts with LCK in a zinc-dependent manner. Ref.9
Subcellular location: Isoform 1: Cell membrane; Single-pass type I membrane protein. Isoform 2: Secreted.
Post-translational modification: All of the five most C-terminal cysteines form inter-chain disulfide bonds in dimers and higher multimers, while the four N-terminal cysteines do not
By similarity.
Involvement in disease: Familial CD8 deficiency (CD8 deficiency) [MIM:608957]: Novel autosomal recessive immunologic defect characterized by absence of CD8+ cells, leading to recurrent bacterial infections.Note: The disease is caused by mutations affecting the gene represented in this entry.
Sequence similarities: Contains 1 Ig-like V-type (immunoglobulin-like) domain.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Pathways associated with anti-CD8a (Ly 2) antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Adaptive Immune System Pathway antibodies | Adaptive Immune System Pathway Diagram |
| Antigen Processing And Presentation Pathway antibodies | Antigen Processing And Presentation Pathway Diagram |
| Antigen Processing And Presentation Pathway antibodies | Antigen Processing And Presentation Pathway Diagram |
| Cell Adhesion Molecules (CAMs) Pathway antibodies | Cell Adhesion Molecules (CAMs) Pathway Diagram |
| Cell Adhesion Molecules (CAMs) Pathway antibodies | Cell Adhesion Molecules (CAMs) Pathway Diagram |
| Downstream Signaling In Naive CD8+ T Cells Pathway antibodies | Downstream Signaling In Naive CD8+ T Cells Pathway Diagram |
| Hematopoietic Cell Lineage Pathway antibodies | Hematopoietic Cell Lineage Pathway Diagram |
| Hematopoietic Cell Lineage Pathway antibodies | Hematopoietic Cell Lineage Pathway Diagram |
| IL12-mediated Signaling Events Pathway antibodies | IL12-mediated Signaling Events Pathway Diagram |
| Immune System Pathway antibodies | Immune System Pathway Diagram |
Diseases associated with anti-CD8a (Ly 2) antibody
| Disease Name | Pubmed Publications |
|---|---|
| Neoplasms Antibodies | >19 publications with CD8a (Ly 2) and Neoplasms |
| Inflammation Antibodies | >16 publications with CD8a (Ly 2) and Inflammation |
| Necrosis Antibodies | >12 publications with CD8a (Ly 2) and Necrosis |
| Cardiovascular Diseases Antibodies | >8 publications with CD8a (Ly 2) and Cardiovascular Diseases |
| Neoplasms, Experimental Antibodies | >7 publications with CD8a (Ly 2) and Neoplasms, Experimental |
| Carcinoma Antibodies | >6 publications with CD8a (Ly 2) and Carcinoma |
| Kidney Diseases Antibodies | >5 publications with CD8a (Ly 2) and Kidney Diseases |
| Liver Diseases Antibodies | >5 publications with CD8a (Ly 2) and Liver Diseases |
| Lymphoma Antibodies | >4 publications with CD8a (Ly 2) and Lymphoma |
| Cerebral Infarction Antibodies | >3 publications with CD8a (Ly 2) and Cerebral Infarction |
Organs/Tissues associated with anti-CD8a (Ly 2) antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >87 publications with CD8a (Ly 2) and Blood |
| Spleen Antibodies | >19 publications with CD8a (Ly 2) and Spleen |
| Liver Antibodies | >12 publications with CD8a (Ly 2) and Liver |
| Thymus Antibodies | >11 publications with CD8a (Ly 2) and Thymus |
| Brain Antibodies | >10 publications with CD8a (Ly 2) and Brain |
| Kidney Antibodies | >10 publications with CD8a (Ly 2) and Kidney |
| Intestine Antibodies | >7 publications with CD8a (Ly 2) and Intestine |
| Lung Antibodies | >5 publications with CD8a (Ly 2) and Lung |
| Connective Tissue Antibodies | >2 publications with CD8a (Ly 2) and Connective Tissue |
| Stomach Antibodies | >2 publications with CD8a (Ly 2) and Stomach |


